Six-minute walking test and its relation to quality of life and lung function in patients with thoracic sequelae of tuberculosis
https://doi.org/10.18093/0869-0189-2013-0-2-69-73
Abstract
Summary. Six-minute walk test (6MWT) is used to evaluate exercise capacity, treatment efficacy and prognosis in patients with chronic heart or lung diseases. The aim of this study was to investigate relations between 6MWT and lung function and health-related quality of life in patients with thoracic sequelae of tuberculosis. The secondary aim was to determine factors affecting functional exercise capacity in such patients.
Seventy patients aged 25–82 years (of them, 41 men and 25 women) were assessed using health status measure, 6MWT, dyspnea scoring and pulmonary function tests. Six-minute walk distance was 520 ± 107 м and correlated closely with quality of life and pulmonary function parameters. The main factor affecting the six-minute walk distance was impaired pulmonary function.
About the Authors
M. I. Chushkin
НИИ фтизиопульмонологии Первого МГМУ им И.М.Сеченова
Russian Federation
Russian Federation
O. N. Ots
НИИ фтизиопульмонологии Первого МГМУ им И.М.Сеченова
Russian Federation
Russian Federation
S. Yu. Mandrykin
Медицинский центр Банка России
Russian Federation
Russian Federation
E. A. Tikhokhod
Медицинский центр Банка России
Russian Federation
Russian Federation
A. S. Belevskiy
ФГБУ "НИИ пульмонологии" ФМБА России
Russian Federation
Russian Federation
N. N. Meshcheryakova
ФГБУ "НИИ пульмонологии" ФМБА России
Russian Federation
Russian Federation
References
1. Вильдерман А.М. Хронические неспецифические заболевания легких у больных туберкулезом органов дыхания. Пробл. туб. 1978; 11: 42–45.
2. Степанян И.Э., Щербакова Г.В., Кубракова Е.П. К вопросу о лечении бронхиальной обструкции у больных туберкулезом органов дыхания. Пробл. туб. 2004; 4: 12–18.
3. Chushkin M., Yartsev S., Zhutikov D. et al. The impairment of respiratory function in patients with treated pulmonary tuberculosis. Chest 2011; 140 (4 Meeting Abstracts): 786A.
4. Palange P., Ward S.A., Carlsen K.H. et al. ERS Task Force. Recommendations on the use of exercise testing in clinical practice. Eur. Respir. J. 2007; 29: 185–209.
5. ATS statement: Guidelines for the six-minute walk test. Am. J. Respir. Crit. Care Med. 2002; 166: 111–117.
6. Ware J.E. Jr., Sherbourne C. The MOS 36-Item short-form health survey. Med. Care 1992; 30: 473–483.
7. Jones P.W., Quirk F.H., Baveystock C.M., Littlejohns P. A self-complete measure of health status for chronic airflow limitation. Am. Rev. Respir. Dis. 1992: 145: 1321–1327.
8. Kupferberg D.H., Kaplan R.M., Slymen D.J., Ries A.L. Minimal clinically important difference for the UCSВ Shortness of breath questionnaire. J. Cardiolpulm. Rehab. 2005; 25: 370–377.
9. Quanjer P.H., Tammeling G.J., Cotes J.E. et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur. Respir. J. 1993; 6: 5–40.
10. Enright P.L., Sherill D.L. Reference equations for the sixminute walk in healthy adults. Am. J. Respir. Crit. Care Med. 1998; 158: 1384–1387.
11. Celli B.R., Cote C.G., Marin J.M. et al. The body-mass index, airflow obstruction, and capacity index in chronic obstructive pulmonary disease. N. Engl. J. Med. 2004; 350: 1005–1012.
12. Cote C.G., Celli B.R. Predictors of mortality in chronic obstructive pulmonary disease. Clin. Chest Med. 2007; 28: 515–524.
13. Frost A.E., Langleben D., Oudiz R. et al. The 6-min walk test (6MW) as an efficacy endpoint in pulmonary arterial hypertension clinical trials: demonstration of a ceiling effect. Vasc. Pharmacol. 2005; 43: 36–39.
14. Caballero A., Torres+Duque C.A., Jaramillo C. et al. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study). Chest 2008; 133: 343–349.
Review
For citations:
Chushkin M.I., Ots O.N., Mandrykin S.Yu., Tikhokhod E.A., Belevskiy A.S., Meshcheryakova N.N. Six-minute walking test and its relation to quality of life and lung function in patients with thoracic sequelae of tuberculosis. PULMONOLOGIYA. 2013;(2):69-73. (In Russ.) https://doi.org/10.18093/0869-0189-2013-0-2-69-73
Views:
1194
Email this article 